While K-ras Is Essential for MouseDevelopment, Expression of the K-ras 4A Splice VariantIsDispensable

REFERENCES

• Adjei, A. A. 2001. Blocking oncogenic Ras signalling for cancer therapy. J. Natl. Cancer Inst. 93: 1062–1074.
   PubMed Web of Science ®Google Scholar
• Ahmadian, M. R. 2002. Prospects for anti-ras drugs. Br. J. Hematol. 116: 511–518.
   PubMedGoogle Scholar
• Apolloni, A. I., A. Prior, M. Lindsay, R. G. Parton, and J. F. Hancock. 2000. H-Ras but not K-Ras traffics to the plasma membrane through the exocytic pathway. Mol. Cell. Biol. 20: 2475–2487.
   PubMed Web of Science ®Google Scholar
• Brooks, D. J., R. M. James, C. E. Patek, J. Williamson, and M. J. Arends. 2001. Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19 (ARF). Oncogene 20: 2144–2152.
   PubMedGoogle Scholar
• Capon, D. J., P. H. Seeburg, J. P. McGrath, J. S. Hayflick, U. Edman, A. D. Levinson, and D. V. Goeddel. 1983. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 304: 507–513.
   PubMed Web of Science ®Google Scholar
• de Castro, I. P., R. Diaz, M. Malumbres, M-I. Hernandez, J. Jagirdar, M. Jimenez, D. Ahn, and A. Pellicer. 2003. Mice deficient for N-ras: Impaired antiviral immune response and T-cell function. Cancer Res. 63: 1615–1622.
   PubMedGoogle Scholar
• Diaz, R., D. Ahn, L. Lopez-Barcons, M. Malumbres, I. P. de Castro, J. Lue, N. Ferrer-Miralles, R., Mangues, J. Tsong, R. Garcia, R. Perez-Soler, and A. Pellicer. 2002. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res. 62: 4514–4518.
   PubMed Web of Science ®Google Scholar
• Ehrhardt, A., G. R. A. Ehrhardt, X. Guo, and J. W. Schrader. 2002. Ras and relatives-job sharing and networking keep an old family together. Exp. Hematol. 30: 1089–1106.
   PubMedGoogle Scholar
• Ellis, C. A., and G. Clark. 2000. The importance of being K-Ras. Cell. Signalling 12: 425–434.
   PubMed Web of Science ®Google Scholar
• Esteban, L. M., C. Vicario-Abejon, P. Fernandez-Salguero, A. Fernandez-Medarde, N. Swaminathan, K. Yienger, E. Lopez, M. Malumbres, R. McKay, J. M. Ward, A. Pellicer, and E. Santos. 2001. Targeted disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21: 1444–1452.
   PubMed Web of Science ®Google Scholar
• Fan, J., and J. R. Bertino. 1997. K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene 14: 2595–2607.
   PubMed Web of Science ®Google Scholar
• Fisher, G. H., S. L. Wellen, D. Klimstra, J. M. Lenczowski, J. W. Tichelaar, M. J. Lizak, J. A. Whitsett, A. Koretsky, and H. E. Varmus. 2001. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumour suppressor genes. Genes Dev. 15: 3249–3262.
   PubMed Web of Science ®Google Scholar
• George, D. L., A. F. Scott, S. Trusko, B. Glick, E. Ford, and D. J. Dorney. 1985. Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumour cells. EMBO J. 4: 1199–1203.
   PubMedGoogle Scholar
• Hancock, J. F. 2003. Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell. Biol. 4: 273–284.
   Google Scholar
• Ise, K., K. Nakamura, K. Nakao, S. Shimizu, H. Harada, T. Ichise, J. Miyoshi, Y. Gondo, T. Ishikawa, A. Aiba, and M. Katsuki. 2000. Targeted deletion of the H-ras gene decreases tumour formation in mouse skin carcinogenesis. Oncogene 19: 2951–2956.
   PubMed Web of Science ®Google Scholar
• Jackson, J. H., J. W. Li, J. E. Buss, C. J. Der, and C. G. Cochrane. 1994. Polylysine domain of K-ras 4B protein is crucial for malignant transformation. Proc. Natl. Acad. Sci. 91: 12730–12734.
   PubMed Web of Science ®Google Scholar
• Janssen, K. P., F. el Marjou, D. Pinto, X. Sastre, D. Rouillard, C. Fouquet, T. Soussi, D. Louvard, and S. Robine. 2002. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 123: 492–504.
   PubMed Web of Science ®Google Scholar
• Johnson, L., D. Greenbaum, K. Cichowski, K. Mercer, E. Murphy, E. Schmitt, R. T. Bronson, H. Umanoff, W. Edelmann, R. Kucherlapati, and T. Jacks. 1997. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11: 2468–2481.
   PubMed Web of Science ®Google Scholar
• Koera, K., K. Nakamura, K. Nakao, J. Miyoshi, K. Toyoshima, T. Hatta, H. Otani, A. Aiba, and M. Katsuki. 1997. K-ras is essential for the development of the mouse embryo. Oncogene 15: 1151–1159.
   PubMed Web of Science ®Google Scholar
• Magin, T. W., J. McWhir, and D. W. Melton. 1992. A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency. Nucleic Acids Res. 20: 3795–3796.
   PubMedGoogle Scholar
• McGrath, J. P., D. J. Capon, D. H. Smith, E. Y. Chen, P. H. Seeburg, D. V. Goeddel, and A. D. Levinson. 1983. Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature 304: 501–506.
   PubMed Web of Science ®Google Scholar
• Pells, S., M. Divjak, P. Romanowski, H. Impey, N. J. Hawkins, A. R. Clarke, M. L. Hooper, and D. J. Williamson. 1997. Developmentally regulated expression of murine K-ras isoforms. Oncogene 15: 1781–1786.
   PubMed Web of Science ®Google Scholar
• Prior, I. A., A. Harding, J. Yan, J. Sluimer, R. G. Parton, and J. F. Hancock. 2001. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat. Cell. Biol. 3: 368–375.
   PubMed Web of Science ®Google Scholar
• Roy, S., R. Luetterforst, A. Harding, A. Apolloni, M. Etheridge, E. Stang, B. Rolls, J. F. Hancock, and R. G. Parton. 1999. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat. Cell. Biol. 1: 98–105.
   PubMed Web of Science ®Google Scholar
• Silvius, J. R. 2002. Mechanisms of Ras protein targeting in mammalian cells. J. Membrane Biol. 190: 83–92.
   PubMed Web of Science ®Google Scholar
• Umanoff, H., W. Edelmann, A. Pellicer, and R. Kucherlapati. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. 92: 1709–1713.
   PubMed Web of Science ®Google Scholar
• Vikis, H. G., S. Stewart, and K. L. Guan. 2002. SmgGDS displays differential binding and exchange activity towards different Ras isoforms. Oncogene 21: 2425–2432.
   PubMedGoogle Scholar
• Voice, J. K., R. L. Klemke, A. Le, and J. H. Jackson. 1999. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274: 17164–17170.
   PubMed Web of Science ®Google Scholar
• Walsh, A. B., and D. Bar-Sagi. 2001. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J. Biol. Chem. 276: 15609–15615.
   PubMed Web of Science ®Google Scholar
• Wang, Y., M. You, and Y. Wang. 2001. Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp. Lung Res. 27: 255–267.
   PubMedGoogle Scholar
• Yan, J., S. Roy, A. Apolloni, A. Lane, and J. F. Hancock. 1998. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273: 24052–24056.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Y. Wang, H. G. Vikis, L. Johnson, G. Liu, J. Li, M. W. Anderson, R. C. Sills, H. L. Hong, T. R. Devereux, T. Jacks, K-L. Guan, and M. You. 2001. Wild-type Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 29: 25–33.
   PubMed Web of Science ®Google Scholar